S

    Standard Biotools Inc (LAB)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.66
    +0.02 (+2.62%)

    Market Cap: $252.00M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(20/40)
    Avg Surprise
    -53.61%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.02
    Range$-0.02 - $-0.02
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.04-75.0%
    60d ago$-0.04-75.0%
    30d ago$-0.04-75.0%
    7d ago$-0.04-75.0%
    Current$-0.02
    Revenue Consensus
    $19M
    Range$19M - $19M
    1 analysts
    Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.03 - $-0.03
    1 analysts
    Revenue Consensus
    $25M
    Range$25M - $25M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.02---
    Jun 26
    		$-0.05$-0.03-66.67%Miss-25.0%
    Mar 26
    		$-0.02$-0.02+0.00%Beat+60.0%
    Dec 25
    		$0.07$-0.05+226.08%Beat+236.0%
    Sep 25
    		$-0.04$-0.02-100.00%Miss-33.3%
    Jun 25
    		$-0.04$-0.04+0.00%Beat+50.0%
    Mar 25
    		$-0.05$-0.04-25.00%Miss+79.2%
    Dec 24
    		$-0.05$-0.03-64.67%Miss+80.2%
    Sep 24
    		$-0.03N/A+57.14%Beat+78.6%
    Jun 24
    		$-0.08$-0.07-14.29%Miss+42.9%
    Mar 24
    		$-0.24$-0.10-140.00%Miss-14.3%
    Dec 23
    		$-0.25$-0.13-92.31%Miss+3.8%
    Sep 23
    		$-0.14$-0.12-16.67%Miss+62.2%
    Jun 23
    		$-0.14$-0.10-40.00%Miss+57.6%
    Mar 23
    		$-0.21$-0.06-250.00%Miss+16.0%
    Dec 22
    		$-0.26$-0.28+7.14%Beat-116.7%
    Sep 22
    		$-0.37$-0.13-184.62%Miss-428.6%
    Jun 22
    		$-0.33$-0.15-120.00%Miss-175.0%
    Mar 22
    		$-0.25$-0.18-38.89%Miss-66.7%
    Dec 21
    		$-0.12N/A+57.14%Beat+7.7%
    Sep 21
    		$-0.07$-0.11+36.36%Beat-333.3%
    Jun 21
    		$-0.12$-0.08-50.00%Miss-71.4%
    Mar 21
    		$-0.15$-0.04-275.00%Miss-15.4%
    Dec 20
    		$-0.13$0.01-1400.00%Miss-333.3%
    Sep 20
    		$0.03N/A+127.27%Beat+133.3%
    Jun 20
    		$-0.07$-0.14+50.00%Beat+30.0%
    Mar 20
    		$-0.13$-0.10-30.00%Miss+7.1%
    Dec 19
    		$-0.03N/A+66.67%Beat+50.0%
    Sep 19
    		$-0.09$-0.09+0.00%Beat+30.8%
    Jun 19
    		$-0.10$-0.07-42.86%Miss+56.5%
    Mar 19
    		$-0.14$-0.10-40.00%Miss+33.3%
    Dec 18
    		$-0.06N/A+68.42%Beat+60.0%
    Sep 18
    		$-0.13$-0.18+27.78%Beat+48.0%
    Jun 18
    		$-0.23$-0.23+0.00%Beat+25.8%
    Mar 18
    		$-0.21$-0.30+30.00%Beat+36.4%
    Dec 17
    		$-0.15$-0.25+40.00%Beat+53.1%
    Sep 17
    		$-0.25$-0.31+19.35%Beat+34.2%
    Jun 17
    		$-0.31$-0.34+8.82%Beat-
    Mar 17
    		$-0.33$-0.56+41.07%Beat-
    Dec 16
    		$-0.32$-0.23-39.13%Miss-
    Sep 16
    		$-0.38$-0.49+22.45%Beat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-15.39EV/EBITDA-19.22x
    Price/FCF-3.12xFCF Yield-32.07%
    Profitability
    Profit Margin100.40%Operating Margin-38.90%
    ROE-11.20%ROIC-12.05%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.10xQuick Ratio8.80x
    Trading Statistics
    Beta1.40Avg Volume1.45M
    52-Week High$1.7252-Week Low$0.63

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.66
    SMA 20$0.71
    SMA 50$0.79
    SMA 200$1.07
    EMA 10$0.67
    EMA 20$0.71
    EMA 50$0.79
    EMA 200$0.99

    MACD

    Line: -0.05Signal: -0.05Hist: -0.00

    ADX

    ADX: 25.3+DI: 10.7-DI: 20.6

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down76.0
    PSAR$0.68

    Bollinger Bands

    Upper Band$0.85
    Lower Band$0.58
    %B Position3765%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    36.6

    Momentum Oscillators

    Stoch %K14.1
    Stoch %D13.5
    Williams %R-81.8
    ROC (10d)-3.8%
    Momentum-0.03
    CCI (20d)-70.1
    MFI (14d)43.2

    Volatility Measures

    ATR (14d)$0.05(7.4%)
    StdDev (20d)0.07
    Hist Vol44.3%(High)

    Volume Flow

    VWAP$0.65
    OBV2.4M
    AD Line-53.9M
    CMF (20d)-0.282

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio1.2x
    VWMA (20d)$0.70

    Pivot Points

    R3$0.70
    R2$0.68
    R1$0.66
    Pivot Point$0.65
    S1$0.63
    S2$0.62
    S3$0.60

    Advanced Oscillators

    TSI-29.08
    Ultimate Osc39.4
    KST-206.34

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$20.10M$21.15M$3.22M$19.55M$21.76M$20.22M$890,000$22.09M$22.49M$45.54M$28.19M$25.37M
    Cost of Revenue$9.57M$9.84M$532,000$10.07M$11.13M$9.17M$2.69M$9.96M$12.12M$21.35M$14.78M$14.21M
    Gross Profit$10.54M$11.31M$2.69M$9.48M$10.63M$11.05M$-1,805,000$12.13M$10.37M$24.19M$13.41M$11.15M
    Operating Expenses$35.92M$23.80M$21.33M$42.42M$36.33M$38.02M$8.54M$38.83M$40.63M$84.37M$34.80M$32.33M
    R&D$1.98M$2.12M$2.08M$6.36M$6.22M$5.44M$-1,332,000$6.94M$7.24M$15.98M$6.96M$6.37M
    SG&A$16.39M$18.61M$16.45M$26.59M$28.11M$29.82M$6.79M$24.47M$24.86M$46.94M$21.35M$22.29M
    Operating Income$-25,388,000$-12,496,000$-18,644,000$-32,938,000$-25,697,000$-26,970,000$-10,343,000$-26,699,000$-30,261,000$-60,182,000$-21,386,000$-21,172,000
    Interest Income$4.61M$3.51M$1.66M$2.14M$2.45M$2.91M$3.90M$4.79M$5.30M$6.21M$4.92M$340,000
    Interest Expense$0$2.12M$5,000$10,000$0$0$572,000$853,000$858,000$1.03M$0$0
    Income Before Tax$-21,435,000$-14,615,000$-19,336,000$-32,900,000$-18,282,000$-23,489,000$-11,162,000$-21,801,000$-25,405,000$-32,029,000$-19,938,000$-20,947,000
    Income Tax Expense$90,000$11,000$-35,900,000$-1,216,000$-609,000$-119,000$257,000$118,000$39,000$128,000$-162,000$50,000
    Net Income$-26,758,000$127.07M$19.28M$-34,687,000$-33,459,000$-26,033,000$-34,072,000$-26,938,000$-45,718,000$-32,157,000$-19,776,000$-20,997,000
    EBITDA$-25,980,000$-17,350,000$-20,164,000$-34,120,000$-17,470,000$-23,073,000$-11,665,000$-23,643,000$-27,877,000$-34,669,000$-17,321,000$-17,471,000
    EBIT$-26,046,000$-18,126,000$-20,993,000$-35,030,000$-20,734,000$-26,403,000$-14,486,000$-25,742,000$-29,849,000$-37,203,000$-20,287,000$-21,287,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LAB

    Government Contracts

    Gov Obligations (TTM)
    $849995
    Gov Obligations / Revenue
    1.0%
    Obligations YoY
    N/A
    Active Awards
    11
    New Awards (TTM)
    5
    Avg Remaining Term
    2.3 mo

    Top agency: Department of Health and Human Services at 63.1% of trailing twelve month obligations across 5 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N94025P00585Department of Health and Human ServicesNational Institutes of Health$507000Sep 10, 2025
    1232SA25P0235Department of AgricultureAgricultural Research Service$136842Aug 21, 2025
    68HE0B25P0717Environmental Protection AgencyEnvironmental Protection Agency$35678Sep 10, 2025
    140FS126P0051Department of the InteriorU.S. Fish and Wildlife Service$15117Feb 26, 2026
    75N92B25P00247Department of Health and Human ServicesNational Institutes of Health$13797Sep 25, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Standard BioTools (NASDAQ: LAB) exec uses 25.7K shares for taxes

    Sean Mackay, SVP & Chief Business Officer at Standard BioTools (NASDAQ: LAB), had 25,729 shares of common stock withheld on August 20, 2026, to cover tax obligations from vested restricted stock units. This transaction, valued at $0.672 per share, resulted in him holding 1,480,823 shares directly afterward. The event is a non-market disposition for tax purposes rather than a sale.

    Stock Titan•8/24/26•
    Neutral

    Standard BioTools (LAB) CFO sees stock withheld for taxes

    Standard BioTools (LAB) CFO Hanjoon Alex Kim had 28,195 shares of common stock withheld on August 20, 2026, to cover tax withholding obligations from vested restricted stock units. This was a "code F" transaction, meaning the shares were withheld for tax payment rather than sold on the open market. After this transaction, Kim directly holds 2,534,859 shares of Standard BioTools common stock.

    Stock Titan•8/24/26•
    Neutral

    Enterprise value to EBIT forward of Standard BioTools Inc. – BX:FLB

    This article focuses on the enterprise value to EBIT forward for Standard BioTools Inc. (BX:FLB). It is presented as a financial data point within TradingView's platform, indicating that the content is likely a snippet from a financial analysis tool rather than an in-depth article. The text primarily consists of navigation and disclaimer information from the TradingView website.

    TradingView•8/21/26•
    Neutral

    Standard BioTools (LAB) holders report 7.3% stake in amended ownership filing

    MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman have filed an amended Schedule 13G, reporting a collective 7.3% ownership stake in Standard BioTools Inc. (LAB). This amounts to 28,813,904 shares of Common Stock, with shared voting and dispositive power among the reporting persons. The filing confirms their passive investment intent, not aimed at changing or influencing company control.

    Stock Titan•8/14/26•
    Neutral

    Standard BioTools (LAB): Long Focus Capital discloses 23.5M shares, 6% passive stake

    Long Focus Capital Management, LLC and its controller, John Helmers, have disclosed a 6.0% passive stake in Standard BioTools Inc. (LAB), representing 23,500,000 shares of common stock as of June 30, 2026. This ownership is held on behalf of their clients, with shared voting and dispositive power, and no single client owns more than 5% of the outstanding common stock. The filing indicates a neutral sentiment and impact.

    Stock Titan•8/14/26•
    Neutral

    Frequently Asked Questions About LAB

    Does LAB pay dividends?
    Standard Biotools Inc (LAB) has a dividend payment track record. See the LAB dividend history page for its current payment status, yield, and streaks.
    What is LAB's market cap?
    Standard Biotools Inc (LAB) has a market capitalization of $252.00M with a current stock price of $0.66.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In